Second Alopecia Areata Trial Demonstrates Hair Regrowth With Baricitinib
Results from 2 studies show statistically significant improvement in scalp hair regrowth with baricitinib, a JAK inhibitor.
Results from 2 studies show statistically significant improvement in scalp hair regrowth with baricitinib, a JAK inhibitor.
The 7-vaccine series provides immunization against diphtheria, pertussis, tetanus, poliovirus, measles, mumps, rubella, hepatitis b, Haemophilus influenze type b, varicella, and pneumococcal infections.
The patient developed a generalized maculopapular rash approximately 3 hours after receiving warfarin.
The investigational adeno-associated virus mediated gene therapy is being developed to deliver the protective APOE2 gene to the CNS.
Add-on voclosporin improved complete renal response across all lupus nephritis biopsy classes, with the greatest benefit observed in pure class 3.
Evekeo ODT, a Schedule II controlled substance, contains a 1:1 racemic mixture of dextroamphetamine sulfate and levoamphetamine sulfate.
MoCD Type A is a rare, inborn error of metabolism caused by mutations in the MOCS1 gene that results in toxic sulfite accumulation in the brain.
The approval was based on data from a phase 3 trial that assessed Ragwitek in 1022 patients 5 to 17 years of age with a history of ragweed-induced rhinoconjunctivitis and sensitivity to short ragweed.
Alternative authorized monoclonal antibody therapies remain available for the treatment of COVID-19.
In a small study, 25% of adults with COVID-19 shed SARS-CoV-2 spike S1 protein in their urine at least once during the course of infection.